The 21 references in paper E. Shikh V., A. Ismagilov D., Zh. Sizova M., O. Demidova A., Е. Ших В., А. Исмагилов Д., Ж. Сизова М., О. Демидова А. (2018) “Безопасность комбинированной фармакотерапии у пациентов пожилого возраста // Safety of combination pharmacotherapy in elderly patients” / spz:neicon:vedomostincesmp:y:2017:i:1:p:47-54

1
Janchawee B, Wongpoowarak W, Owatranporn T, Chongsuvivatwong V. Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand. J Clin Pharm Ther. 2005; 30(1): 13–20.
(check this in PDF content)
2
Belousov YuB, Leonova MV. Features of the application of drug in geriatric practice. Farmateka 2008; (8): 13–9 (in Russian).
(check this in PDF content)
3
Yarygin VN, Melentiev AS, eds. Guidelines for Gerontology and Geriatrics. V. 3. Clinical Geriatrics. Moscow: GEOTAR-Media; 2007 (in Russian).
(check this in PDF content)
4
Mizusawa Y, Wilde AA. QT Prolongation and Mortality in Hospital Settings: Identifying Patients at High Risk. Mayo Clin Proc. 2013; 88(4): 309–11.
(check this in PDF content)
5
Anatomy and physiology of the digestive tract. Directory. Cytochrome P450 (isozymes CYP2C19 and CYP3A4). Available from: http://www.gastroscan.ru (in Russian).
(check this in PDF content)
6
Starodubtsev AK, Maksimov ML. Pharmacokinetics of drugs in elderly patients. In: Kukes VG, ed. Clinical Pharmacokinetics: theoretical, applied and analytical aspects. Guideline. Moscow: GEOTAR-Media; 2009 (in Russian).
(check this in PDF content)
7
Maneshina OA Belousov YuB. Polypharmacy and drug interactions in elderly patients. Kachestvennaya klinicheskaya praktika 2008; (3): 90–3 (in Russian).
(check this in PDF content)
8
McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002; 36(9): 1331–6.
(check this in PDF content)
9
Hohl CM, Dankoff J, Colacone A, Afilalo M. Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emer Med. 2001; 38(6): 666–71.
(check this in PDF content)
10
Kuzdenbaeva RS, Aldabergenova KU. What is polypharmacy and how to avoid it? Available from: https://goo.gl/Os9lWp (in Russian).
(check this in PDF content)
11
Combined List of Drugs that Prolong QT and/or cause Torsades de Pointes (TdP). Available from: https:// www.crediblemeds.org.
(check this in PDF content)
12
Limankina IN. Long QT Syndrome and safety problems of psychopharmacotherapy. Vestnik aritmologii 2008; 52: 66–71 (in Russian).
(check this in PDF content)
13
Long QT Syndrome. Symptoms and signs. Available from: http://www.medmoon.ru/bolezni/bol43l.html (in Russian).
(check this in PDF content)
14
Arsentieva RH. Long QT Syndrome. Vestnik sovremennoy klinicheskoy meditsiny 2012; 5(3): 72–3 (in Russian).
(check this in PDF content)
15
Ushkalova EA. Medicines and QT interval. Farmateka 2001; (7): 45–53 (in Russian).
(check this in PDF content)
16
Pickham D, Helfenbein E, Shinn JA, Chan G, Funk M, Weinacker A, et al. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: Results of the QT in Practice (QTIP) Study. Critical Care Medicine 2012; 2(40): 394–9.
(check this in PDF content)
17
Fomin E, Baychorov I, Shikh E, Sizova Zh. Pharmacotherapy for patients with comorbidity: possible drug interactions at the level of metabolism. Vrach 2014; (1): 13–7 (in Russian).
(check this in PDF content)
18
Furman NV, Shmatova SS. Clinical significance of drug-induced intervals QT and QTc prolongation. Ratsionalnaya farmakoterapiya v kardiologii 2013; 9(3): 311–5 (in Russian).
(check this in PDF content)
19
Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006; 15(3): 179–84.
(check this in PDF content)
20
Delafuente JC. Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003; 48(2): 133–43.
(check this in PDF content)
21
Johnell K, Klarin I. The Relationship between Number of Drugs and Potential Drug-Drug Interactions in the Elderly: A Study of Over 600000 Elderly Patients from the Swedish Prescribed Drug Register. Drug Safety 2007; 30(10): 911–8. AUTHORS
(check this in PDF content)